Thursday, 12th November Clinical Oncology Society of Australia Annual Scientific Meeting 2026

For more information, visit the Breakfast Sessions page. 

• Precision starts with Visibility: Demographic Reporting in Australian Cancer Clinical Trials - Gowri Shivasabesan
• Beyond Country of Birth: The Importance of Ethnicity Data in Achieving Equitable Precision Cancer Care   - Mei Ling Yap
• From Prevention to Personalised Care for All: ALLCLEAR’s Equity Workstream as a Model for Improving Rural, First Nations and CALD Participation in Precision Oncology Research - Fisaha Tesfay
• Ethical and collaborative inclusion of Indigenous communities in precision generation research. - Jakelin Troy
• Reimagining Precision Cancer Care: Community‑Led Chinese Support Integration and Arabic Research Navigation to Boost Research Literacy and Trial Access - Abhijit Pal
• Fostering a culture of health equity within health systems - Sabe Sabesan
• Validation of a Co-designed Multilingual AI Chatbot for Equitable Cancer Care in Culturally and Linguistically Diverse Communities (Cancer-TRUST)  - Alexandra Stacy

This session includes a 15-minute panel discussion.

• Towards precision care for older patients with Head and Neck cancer: External validation of a multi-endpoint outcome prediction model in an Australian radiotherapy cohort - Farhannah Aly
• Bridging the Gap: Aligning Healthcare Professional and Consumer Expectations for Pharmacogenomics in Cancer Care - May Darwish
• Can Oxaliplatin neurotoxicity be reduced with ibudilast in people with colorectal cancer (CRC)? OXTOX – a phase II placebo-controlled randomised trial   - Haryana Dhillon
• A Prospective Study Correlating CLDN18 IHC and mRNA Expression in Gastrointestinal Cancers: Unveiling the Value of TargeteGITd Transcriptomics - Joachim Fluhrer
• Intra-tumoural manganese is associated with radioresistance and overall survival in glioblastoma - Gerald B Fogarty
• Evaluating a Consortium-Based Molecular Tumour Board: Improving Access to Precision Oncology Across Metropolitan and Regional Victoria - Lama Karroum
• Ovarian tissue oocyte retrieval and vitro maturation: Expanding fertility preservation options for oncology patients - Anastasia Kirillova
• Proton pump inhibitor use and atezolizumab efficacy and safety: an individual participant data meta-analysis of 12 randomised trials - Lee Li
• FIRSTCARE - Nurse-led ePROM monitoring of older adults during anti-cancer treatment at a metropolitan cancer centre in Australia  - Thilo Schuler
• Predicting hospitalisation in patients with lung cancer - a model for personalised care - Sheng Xiang Franklin SXF Chen
• Cost-Effectiveness and Budget Impact of PD-L1–Guided Pembrolizumab Strategies in Advanced Non–Small Cell Lung Cancer - Srinivas Teppala
• Precision Prostate Survivorship: Developing a Nurse-Led PSA Surveillance and ePROMs Model - Catherine L White

• The promise and the practice: What precision cancer care means when you're living it - Lillian Leigh
• Transforming outcomes in lung cancer with Precision Medicine - Ben J Solomon
• Living longer for whom? Equity and access in advanced cancer - Tara C Horrill
• Optimising advanced cancer care in a minefield of misinformation and limited evidence: insights from an exercise and dietary trial in metastatic breast cancer - Marina M Reeves

This session includes a 15-minute panel discussion. 

• What we are told and believe - Elisabeth Kochman
• Cancer beyond the factory gate - Tim Driscoll
• Getting on the clinical radar: Communicating occupational cancer risk to primary care - Matthew Govorko
• Cancer from pollution & consumer products: what is the highest priority? - Terry Slevin
• Loss or damage from industry caused cancer:  compensation, and how to prevent or reduce harm - Neil Francey

• Embedding genomics into the Australian health system: the National Health Genomics Policy Framework and Implementation Plan - Erin Heyer
• Implementing the National Framework for Genomics in Cancer Control: early progress and next steps  - Vivienne Milch
• Advancing Aboriginal and Torres Strait Islander genomics: reflections on national implementation priorities - Louise Lyons

This session includes a 45-minute panel discussion and will be joined by Prof David Thomas and Krystal Barter.

• The role of oncologists in prescribing exercise medicine  - Ash Malalasekera
• Precision exercise medicine for bone health - Nicolas Hart
• Moving towards a precision exercise medicine approach to optimise cardiovascular health in cancer survivors - Erin Howden
• A Moving Target: approaches to be more precise with exercise prescription to enhance adherence in cancer - Brent Cunningham

This session includes a 30-minute panel discussion. 

• Why PROs matter to people with cancer - Susan Hayes
• Executive Sponsorship Matters: Lessons from Successful and Unsuccessful Implementation of Patient-Reported Measures in Cancer Care - Michael Osborn
• The Critical Role of Clinical Leadership in Embedding PROMs into Routine Care - James Lynam
• Moving the dial: policy levers for embedding routine patient-reported measures into cancer care - Shelley Rushton
• Law, policy and lasting change in cancer control - Hayley E Jones

This session includes a 10-minute panel discussion. 

• Innovations in Supportive Cancer Care: Cost-Effective Integration of Exercise Oncology into Radiotherapy Care - Kim Edmunds
• Embedding patient-reported measures into routine radiation oncology practice: Research Translation into Practice - Elise Smith and Olivia Farquhar
• CarersCanADAPT: Results from a national randomised controlled trial of an internet-delivered psychological therapy program for cancer carers - Rebekah Laidsaar-Powell
• An educational resource to guide cancer carers decisions about seeking emotional support: Pilot evaluation of the CarersCanACCESS website  - Rebekah Laidsaar-Powell
• Personalised care beyond treatment: Opportunities to address the financial toxicity of childhood cancer - Axelle Marjolin
• Pre-existing and post-cancer major cardiovascular disease and their association with mortality outcomes among cancer survivors in New South Wales - Mijanur Rahman
• PRIORITY-CONNECT SMS: an AI avatar-based model of perioperative support for gastrointestinal cancer surgery - Tiffany R Tsoukalas

Tom Reeve Award and oration, 2026 recipient Professor Bogda Koczwara AM

• Turning Evidence into Action: Using Real-World Cancer Data to Drive Change - Sallie-Anne Pearson
• From data to impact: the digital foundations for modern cancer care  - Richard Taggart
• From Data to Action: Using Clinical Dashboards to Drive Quality Improvement in Cancer Care - Shalini K Vinod and Merran Findlay

• Precision without the price: strategies to minimise cardiopulmonary toxicity in lung radiotherapy - Vicky J Chin
• Exercise as Treatment: Optimising Lung Cancer Outcomes with Pre and Rehabilitation - Lara Edbrooke
• Following the Tumour in Real Time: Liquid Biopsy Across the Disease Trajectory - Malinda Itchins
• Beyond Traditional Models: The Advanced Oncology Nurse’s Role in Whole-of-Journey Lung Cancer Care - Cassandra J Mazza

• Death Anxiety as a Driver of Existential Distress in Cancer: Implications for Assessment and Intervention - Rachel E Menzies
• Meaning, mortality and palliative care: Responding to distress at the end of life - Jennifer Philip
• Mortality, meaning, and saying goodbye: Clinical psychology approaches to managing existential concerns in advanced cancer - Baby Foo
• Safe delivery of psilocybin-assisted therapy in oncology: trial evidence and stakeholder perspectives - Suzanne Grant

This session includes a 30-minute panel discussion. 

• The emerging role of CNS precision oncology - Hao-Wen Sim
• When Brain Cancer Meets Trauma: Rethinking Support Through a Trauma-Informed Lens - Megan Jeon
• Neuropsychological assessment and interventions for people with brain tumours - Kerryn E Pike
• Rehabilitation in people living with CNS cancers - Stephanie Lam

This session includes a 20-minute panel discussion and will be joined by Nicola Cove and Christine Whittall.

• Preparing patients for genomic testing in the era of precision oncology: Results from the Consent for Genomic Testing (CoGenT) randomised pilot trial - Jolyn Hersch
• Development and Validation of a Real-Time Electronic Frailty Index in Geriatric Oncology - Penny Mackenzie
• Implementation evaluation of a molecular multidisciplinary team supporting integration of precision oncology into routine cancer care - Skye McKay
• Towards precision palliative care: International Delphi consensus on optimal timing of palliative care communication for adolescents and young adults with cancer - Ursula M Sansom-Daly
• FIRSTCARE - Implementing ePROM-based frailty assessment for older adults into routine care at a metropolitan cancer centre in Australia - Thilo Schuler
• Who should be screened for melanoma? Identifying the best risk level for a proposed national screening program in Australia - Aminath Shausan

• Identification of policy levers to address financial toxicity in people affected by cancer: a scoping review   - Ashleigh R Sharman
• Navigating Job Security After Cancer: A Legal and Policy Review to Inform Survivorship Care - Laurelie R Wishart
• Financial toxicity in head and neck cancer survivorship: evidence, lived experience and advocacy on prosthetic rehabilitation gaps.  - Nadia Rosin
• Moving medicines access policy in Australia: the use of pan-tumour evidence and patient advocacy - Sarah Benger
• Financial Toxicity in Regional and Rural Cancer Survivors in Australia: From Co-Design to Implementation of a Holistic Support Program (FINHOPe)  - Susannah Ayre
• Responding to financial hardship in childhood cancer amid a changing cost-of-living environment: Redkite’s tiered financial assistance model   - Bridget Rowe-Sykes

This session includes a 25-minute panel discussion, "Collaboration and Partnerships for Action", and will be joined by Megan Varlow and Carla Thamm. 

For more information, visit the Dinner Symposia page. 

• Bridging the gap: Engaging GPs in the lifelong care of childhood cancer survivors - Kate Alford
• Pregnancy-Associated Cancer Awareness in Patients and Healthcare Professionals: Knowledge Gaps and Digital Education Strategies - Muyun (Sarah) Cao
• The inherited cancers experience: listening, learning, and co-designed resources - Lisa Caterina
• Empowering Regional Cancer Care: A National Educational Support Strategy for the regional cancer workforce  - Lucinda Clarke
• Beyond Written Information: Supporting Health Literacy and Self-Efficacy Through Co-Designed Cancer Information - Elisabeth Coyne
• Tackling the taboo: Building workforce confidence to address sexual health in cancer care - Kathe Holmes
• Building a specialist workforce: An education program for top-of-scope melanoma nursing - Kathe Holmes
• Building primary care capacity for Lymphoedema: Development of Australia's National GP education guide - Debbie Geyer
• Co-design of sarcoma specific digital consumer resources for people diagnosed with sarcoma and their carers: SUN-SHINE - Georgia KB Halkett
• Improving Cultural Safety in Clinical Research: A Systematic Review of Interventions to Improve Research Literacy and Clinical Trial Engagement in Multicultural and First Nations Populations - Athulya Harikrishna
• Supporting precision colorectal cancer prevention in general practice: the Refer4Scope tool and education program - Christopher Horn
• “Helping pharmacists to become recognised as experts and key reference points in pharmacogenomics”: A mixed methods evaluation of an accredited pharmacogenomics education program - Safeera Y Hussainy
• Community members as research partners: A scoping review of consumer training programs in cancer research - Lizzy Johnston
• How does building legal capacity prevent cancer? - Hayley Jones
• Frailty and Cancer:  Development and Implementation of an eviQ educational resource - Michael Krasovitsky
• Narrative Medicine and the Written Word: Creative Writing as a Tool for Health Professional Well-Being in Oncology - Michael Krasovitsky
• Diagnostic Challenges in Immune Checkpoint Inhibitor-Mediated Triple M Syndrome: A case highlighting diagnostic uncertainty.  - Jonathan Loh
• Addressing future workforce capability needs in haematology and cellular therapies - Tia Moeke
• Supporting workforce capability through contemporary immunotherapy education - Tia Moeke
• Improving occupational cancer recognition and referral - Tia Moeke
• Building cancer workforce capability: a network strategy and experience - Linda Nolte
• Lead from Lived Experience: Integrating consumer leadership in the cancer sector    - Pauline Ryan
• Prioritising Lived Experience Expertise in Regional Cancer Workforce Education - Lucinda Clarke
• Effects of Group Education on Bladder and Bowel Preparation Compliance in Radiation Therapy Prostate Patients - Elise Smith
• Using AI-simulated conversations to build cancer workforce communication capability - Kyleigh Smith
• Embedding emotional safety in consumer involvement: development of a resource for consumers and researchers - Gill Stannard
• A survey of Australian cancer patients regarding current education practices - Marisa Stevens
• Exploring Australian cancer nurses' practices in patient education: Addressing seven domains of care - Marisa Stevens
• Empowering lived experience voices in childhood cancer research funding - Sarah E Stewart
• From co-design to care: Developing a national nurse-led mental health program for people living with multiple myeloma  - Rayan Saleh Moussa
• Timely palliative care: a practical framework - Simon Waring
• Validation of an Occupational Exposure Risk Assessment Tool for the preparation of pharmaceutical and advanced therapeutic products in Australian hospitals - Kerry Watts
• Scrolling to safety: Using social media to deliver evidence-based microlearning to cancer health professionals. - Laura Wuellner
• Understanding pathways for genetic testing and counselling for women with ovarian cancer in New South Wales - Abigail Acosta
• Increasing uptake of supervised exercise among patients in a prehabilitation service at a tertiary cancer centre: a qualitative improvement initiative - Morgan Smith
• The McGrath Model of Care – Haematological Cancers - Vanessa N Brunelli
• Synthetic Creation of OMOP Oncology Patients (SCOOP) - Georgina Kennedy
• What is the level of adherence and the factors influencing it for Lung Cancer Optimal Care Pathways in Australia?   - Matthew Armstrong
• Establishing the Older Adult Sunshine Coast Integrated oncology Service (OASIS) at Sunshine Coast Hospital and Health Service  - Shona Baker
• Body composition and access to dietetic care during treatment: Missed opportunities in ovarian cancer?  - Sarah Benna-Doyle
• From Paper to Digital: Standardising Pharmacist Clinical Verification for Oral Anticancer Therapies in the Electronic Medical Record - Kyle Booth
• monarchE: Primary overall survival (OS) results of adjuvant abemaciclib + endocrine therapy (ET) for HR+, HER2-, high-risk early breast cancer (EBC) - Fran Boyle
• monarchE: Subgroup analysis of adjuvant abemaciclib + endocrine therapy (ET) for HR+, HER2-, high-risk early breast cancer (EBC) by nodal status - Fran Boyle
• Sexual Health Matters: Understanding the information needs of female cancer survivors - Sophie Broderick
• Patient preferences regarding radiation therapy for prostate cancer: a health preferences study  - Amy Brown
• Designing the PanCancer National Core Outcome Set Coverage Tool for patient-reported outcomes in cancer care: Stakeholder priorities for tool features and functionality - Mollie Cahill
• Patient preference for first-line treatment of locally advanced or metastatic urothelial cancer (Ia/mUC) in Australia, South Korea and Taiwan - Marie Lou Camara
• Real-world patient characteristics and treatment patterns in locally advanced or metastatic urothelial cancer (Ia/mUC) in Australia and Taiwan - Marie Lou Camara
• Establishing best practices to prevent and manage lower limb lymphedema in patients who have been treated for cervical cancer - Susan Elisabeth Yuill
• Evaluating patient experience in an outpatient rural psycho-oncology clinic - Saji Chathanchirayil
• What are the rate, experiences and outcomes for people from minority ethnic and cultural groups affected by of cancer-related lymphoedema? A systematic review and narrative synthesis.  - Ashfaq Chauhan
• Standardising Lung Cancer Diagnostic Pathways: A State-wide Workflow Model for the National Lung Cancer Screening Era - Vanessa N Brunelli
• Time spent exercising after completion of adjuvant treatment - Eric Chen
• Feasibility and challenges of measuring lung cancer quality indicators using linked registry data: lessons from New South Wales     - Kim-Lin Chiew
• Effectiveness of interventions that enable head and neck cancer patients to self-manage their oral and dental health: a systematic review. - Harsha Chugh
• Tailored digital support for parents of children and adolescents with cancer: lessons from the COMPASS program pilot  - Jennifer Cohen
• Prevalence of, and factors associated with, self-reported kit non-receipt in the Australian National Bowel Cancer Screening Program  - Katelyn Collins
• ePROMs in routine cancer care: are they worth the investment? a cost-effectiveness analysis - Louisa Collins
• LGBTIQA+ Visibility and Inclusion in South Australian Cancer-Treatment and Service Organisation Websites - Daniel G Coro
• Developing Australia's National Cervical Cancer Management Guidelines: a national collaborative approach to evidence-based and equitable care - Susan Yuill
• Quality indicators used in population cancer screening programs and their applicability to targeted melanoma screening: a scoping review - Candice Donnelly
• Healthcare professionals’ perspectives on the barriers and enablers of cancer clinical trial participation among Arabic-speaking cancer patients in Australia: a qualitative study - Layla Edwards
• Factors influencing participation in cancer clinical trials among Arabic-speaking communities in Australia: a qualitative study - Layla Edwards
• Delirium in outpatient cancer care settings: A qualitative exploration of clinicians’ perspectives and experiences to identify opportunities for improvement - Layla Edwards
• Strengthening the Aboriginal and Torres Strait Islander cancer care workforce through First Nations leadership and system-wide collaboration - Claire Howlett
• Navigating Pediatric Cancer Care: Parents' Perspectives on Healthcare Access and Service Delivery in Indonesia - Nur Fadilah
• Understanding implementation of a multicomponent colorectal cancer screening intervention in Australian general practice  - Eleonora Feletto
• Scaling and Spreading Survivorship Models of Care to local context - Frezsa Fulia
• From Mapping to Implementation: A Statewide Framework for Scaling Evidence-Based Cancer Survivorship Care - Frezsa Fulia
• Evaluating socioeconomic inequities in colorectal cancer screening in Australia - Eleonora Feletto
• Beyond counting participants: a method for evaluating Australia's cancer clinical trials infrastructure - Martha Gerges
• Mapping and strengthening regional skin cancer services: a population health approach in the Loddon Mallee Region.     - April Gerolemou
• Building community capacity to improve culturally safe cancer care for refugee communities: Lessons from a regional Victorian service improvement initiative - April Gerolemou
• Reaching elimination of cervical cancer in New South Wales (NSW): the potential of HPV testing during antenatal care in hospitals to increase participation in cervical screening - Sarah Gerritsen
• Which interventions improve adherence to optimal care pathways for lung cancer in australia? a systematic review and narrative synthesis.   - Keya Giri
• Development of a statewide Aboriginal Cancer Coordination Model of Care and Framework to strengthen culturally safe cancer care across Victoria - Shannon Gleeson
• Unwarranted variation in cancer care for culturally and linguistically diverse populations in Victoria: implications for equitable and optimal care - Frances F Graham
• Emergency Presentation Prior to Cancer Diagnosis in Victoria: Identifying Variation in Diagnostic Pathways Across Culturally and Linguistically Diverse Populations - Frances F Graham
• A statewide consultation framework to identify barriers and enablers to optimal cancer care - Frances F Graham
• Reducing transport emissions in systemic therapy delivery to adult oncology patients, climate-responsive cancer-care. - Indika Gunadasa
• Australian GP perspectives on preventing and managing weight gain in breast cancer survivorship - Lisa Hanlon
• Implementation challenges and support needs: oncology management system rollout across regional WA  - Sarah Heward
• Direct access colonoscopy – evaluation of the health system impact of a new model of access to diagnostic investigation - Christopher Horn
• Factors influencing engagement with personalised survivorship recommendations in childhood cancer survivors - Rachel E Houweling
• Is remote survivorship assessment, equally accurate for everyone? - Rachel E Houweling
• Childhood cancer survivors’ participation in everyday life: long-term difficulties with activities of daily living and implications for occupational therapy - Rachel E Houweling
• The unmet sexual health needs of patients and the cancer workforce: A tale of two trigger films. - Safeera Y Hussainy
• When every population is a priority: a structured multi-criteria framework for cancer equity action   - Kate Ioannou
• Mapping patient education, counselling and support needs across the cancer care journey - Tara M Isaacs
• Patient experience of a bundled care model for early-stage breast cancer in the Australian private health system: Addressing fragmentation and price opacity - Michael Jameson
• Opportunities for integrated health service responses to the legal and financial impacts of cancer - Hayley Jones
• Learnings from the Optimal Care Pathway for people living in rural and remote areas with cancer: Recommendations to support the development of equitable cancer pathways - Hannah Jongebloed
• Equitable Lung Cancer Care Through Telehealth-Integrated Rapid Access Clinics - Abhishek Joshi
• Findings from the 2-year evaluation of the Australian Cancer Plan - Katrina Anderson
• Managing multimorbidity in cancer: Results of consultation with Australian consumers and healthcare professionals to inform a clinical pathway - Emma Kemp
• Implementing a nurse-led geriatric oncology model of care for older people with lung cancer: A longitudinal evaluation using the Consolidated Framework for Implementation Research - Nicole Knox
• Endometrial Cancer in Western NSW  - Liangyu Lai
• Variation in dispensing of oral anti-cancer medications across remote, rural, regional and metropolitan areas of Australia - Michael J Leach
• Australian healthcare professionals' experiences providing care to people with co-occurring cancer and serious mental illness - Morgan Leske
• Co-designing a pragmatic, risk-stratified nutrition model of care for people with cancer: integrating patient, carer and nutrition expert perspectives - Jenelle Loeliger
• Free doesn't mean accessible: Barriers to exercise engagement in young-onset colorectal cancer patients - Molly Lowther
• Biliary intervention in oncology inpatients: timeliness and outcomes. - Nina Marquard-Karp
• Improving access to therapy - how increasing capacity and visibility of cancer therapy in Western NSW has increased uptake of cancer treatments - Claire Mason
• Quantifying pharmacy service resource requirements in clinical trials: Pilot study of a novel complexity model - Geetha Mathew
• Early utilisation and engagement patterns in a newly established psycho-oncology service   - Elizabeth Matthews
• Embedding psychology within oncology: improving access to psycho-oncology care in a tertiary cancer service  - Elizabeth Matthews
• Reimagining Pre-operative Cancer Nutrition Care: Co‑Designing a Digital Patient-led Approach to Malnutrition Screening  - Shane McAuliffe
• Co-design and collaboration: Elevating the voices of adolescents and young adults with cancer through multistakeholder ownership of a national study on experiences of cancer care - Fiona EJ McDonald
• Operationalising smoking cessation models of care in oncology settings: A mixed-methods systematic review - Melissa T McEnallay
• Clinician Perspectives on Voluntary Assisted Dying in NSW: Findings from the First 18 Months of Implementation  - Gemma McErlean
• A prospective feasibility study of a physiotherapy hybrid model of care for people undergoing curative radiotherapy for head and neck cancer (HANC) - Christopher J McHardy
• Schwartz rounds and staff compassion in a quaternary cancer centre: a prospective observational cohort study - Brendan McLucas
• Factors Affecting Clinical Trial Offer, REview and Discussion (FACTORED) for cancer patients in rural Victoria, Australia - Narelle McPhee
• Long term efficacy of adjuvant abemaciclib + endocrine therapy (ET) in key subgroups in the monarchE trial - Bincy Thampi
• One less visit matters: personalising palliative radiotherapy care - Daniela Miller
• Improving clinical trial access, awareness and collaboration across NSW: Findings from a statewide program evaluation - Melissa Minett
• Collaboration for implementation success - Lung Cancer Screening in NSW - Mary M Mitchelhill
• Building a Learning Health System for Bladder Cancer: Translating Data into Quality Improvement Through the RBCO Knowledge Forum - Ruyamuro Kwedza
• Despite triage efforts, residual patient harm persists in a regional medical oncology service - Cuong Nguyen
• A moving feast: operationalising critical weight loss definitions in a real-world head and neck cancer cohort - Ghazaleh Niknam Shirvan
• Investigating unwarranted variation in head and neck cancer care: From statewide data to local service improvement - Linda Nolte
• Pregnancy-associated cancer in Victoria: population-based insights to inform coordinated, equitable care - Linda Nolte
• Exploring the experiences and perspectives of consumers involved in cancer research - Moira O'Connor
• Fertility and sexual health in young-onset colorectal cancer: current practice around fertility discussion and preservation at an academic Australian cancer centre - Charlotte A O'Leary
• Avoiding preventable emergency presentations: outcomes of the Rapid Access Clinic Expansion (RACE) service at a tertiary regional cancer centre  - Martina O'Neill
• Integrated advanced nursing practice: development and evaluation of a collaborative oncology care model  - Martina O'Neill
• Improving Equitable Access to Chemotherapy Through Data-Driven Capacity Optimisation: A Quality Improvement Initiative Across Western Health    - Paola Ortiz Barillas
• Implementation of Optimal care pathway for Lung Cancer in Regional cancer centre - Otty Zulfiquer
• Implementing Optimal Care Pathway Improves Timeliness of Care for People with Lung Cancer - Otty Zulfiquer
• Analysis of single patient use protocol applications for cancer treatment to the SA Health Cancer Drug Committee (SAHCDC) - Shreya Parmar
• From reactive to proactive: Embedding physical function screening into routine chemotherapy care (PACER Pathway) - Lisa E Parry
• Reflections on an Oncosexology Community of Practice:  Are there barriers to moving from Interest to Action? - Krista Phillips
• Cancer Rehabilitation and Physical Activity in Low- and Middle-Income Countries: From Evidence Mapping to Implementation Perspectives in the Solomon Islands - Alanah Pike
• Use of a novel AI algorithm to identify topological and histone modification marks to infer multilevel polygenic expression in Leukemia - Athula K Polonowita
• Olomorasib and immunotherapy in stage II-III KRAS G12C-mutant NSCLC after definitive therapy: SUNRAY-02 study rationale - Aarohan Pruthi
• Final update for safety and efficacy of selpercatinib in first line patients with RET-fusion positive thyroid cancer: data from LIBRETTO-001 - Aarohan Pruthi
• Selpercatinib in pediatric and adolescent patients with RET-altered solid tumors: safety and efficacy results from the phase 1/2 LIBRETTO-121 study - Aarohan Pruthi
• Event-free survival (EFS) with adjuvant selpercatinib in stage IB-IIIA RET fusion-positive (RET+) NSCLC: primary results of the phase 3 LIBRETTO-432 trial - Aarohan Pruthi
• First-line (1L) olomorasib + chemoimmunotherapy (chemo-IO) in KRAS G12C-mutant NSCLC: updated results from the LOXO-RAS-20001 and SUNRAY-01 trials - Aarohan Pruthi
• First-line (1L) olomorasib + pembrolizumab in KRAS G12C-mutant NSCLC: updated results from LOXO-RAS-20001 and SUNRAY-01     - Aarohan Pruthi
• Intracranial efficacy of olomorasib, a next-generation KRAS G12C inhibitor, in patients with KRAS G12C-mutant NSCLC who have active, untreated brain metastases   - Aarohan Pruthi
• Closing the gap: lung cancer screening, early detection and rapid access nodule assessment in the Townsville Hospital and Health Service   - Pradeep Rajagopalan
• Exhausted but engaged: Understanding burnout and work engagement among Australian advanced practice cancer nurses - Anjali Chamika Rathnayaka Mudiyanselage
• Measuring what matters: building a national pan cancer PROMs and PREMs standard for cancer. - Huw Rees
• From diagnostic uncertainty to coordinated care: Mid-trial implementation lessons from a consumer-informed new model of care for suspected cancer of unknown origin (SUPER-ED Trial) - Natalie Richards
• The evolving role and potential of the Cancer Care Nurse Practitioner in optimising rural cancer care. - Kacy Ringshaw
• Measuring what matters: A systematic review of approaches to assess adherence to clinical guidelines and care pathways in healthcare delivery  - Helena Rodi
• Can we measure adherence to Optimal Care Pathways? A participatory action research program to strengthen cancer care  - Helena Rodi
• Consumer-informed priority setting to improve breast cancer services: A co-designed framework for health system improvement  - Helena Rodi
• Utility Values Following Surgery for Colorectal Cancer: a Systematic Review and Meta-analysis - Nicholas A Rose
• Developing a Cancer Clinical Educator Model: A Multi-Site Initiative - Kate Ross
• Lung Cancer Patterns of Care and Patient Pathways in a High-Volume Referral Campus - James Ryan
• Strengthening cancer medication safety and workforce capability in Cambodia: A multi-phase capability-building initiative  - Marissa Ryan
• International collaboration for cancer care improvement: An evaluation of a work shadowing experience by Cambodian clinicians at an Australian tertiary hospital     - Marissa Ryan
• From Breakthrough to Bedside: Evidence Characteristics Associated with Timely Australian Access to Precision Cancer Therapies - Sherrie Sadri
• Co-developing the CALD-PC navigator program for NSW palliative care services - Rayan Saleh Moussa
• What do we mean by ‘lived experience leadership’? Getting precise about defining the role of lived experience in cancer research leadership - Ursula M Sansom-Daly
• Impact of a Standardized Chemotherapy Pre-Printed Order on Medication Safety in Gynecologic Oncology: A Pre–Post Quality Improvement Study at a Super-Tertiary Hospital in Thailand - Natchanon Sathapanapitagkit
• From Policy to Practice: Financing the Precision Cancer Agenda in Lung Cancer Screening and Care - Shaz Sazali
• Experiences and needs of BreastScreen NSW staff for communicating with older women about cessation of breast screening invitations - Ashleigh R Sharman
• A multidisciplinary region-wide implementation collaborative to accelerate readiness for the National Lung Cancer Screening Program  - Robert Sharrock
• Implementing the National Lung Cancer Screening Program: Early experience from a metropolitan Melbourne region implementation support model - Robert Sharrock
• Driving system-wide cancer care reform across Victoria, through a statewide cancer service improvement network - Seleena Sherwell
• Development, implementation and evaluation of online training for cancer services health professionals on routine collection of patient-reported outcome measures - Puma Sundaresan
• Role of a pharmacist in outpatient allograft transplant care. - Jim Siderov
• Investigating the timeliness of zoledronic acid initiation in adjuvant and neoadjuvant breast cancer patients.  - Jim Siderov
• Do machine learning models outperform logistic regression for risk stratification in resource-constrained settings? insights from a real-world cohort with implications for oncology care - Sachpreet Singh
• Core competencies for facilitators of metastatic cancer support groups: insights from a national consultation to inform curriculum development - Andrea L Smith
• Impact of Multidisciplinary Team Care on Patient-Reported Outcomes in Patients with Lung Cancer: A Systematic Review - Aastha Srivastava
• Examining Barriers and Enablers to Radiation Medicine Related Research Conduct and Participant Recruitment in Regional and Rural Australia - Puma Sundaresan
• Availability of cancer rehabilitation, fitness and recreation services in Victoria: a geospatial analysis using a population-based cohort - Germaine Tan
• Ensuring representativeness, diversity and applicability: Exploring the composition of expert working group members developing cancer-specific Optimal Care Pathways - Sherry (Xueying) Tang
• Pilot Implementation of a Bilingual Trial Navigator for Arabic-Speaking Patients with Cancer in South Western Sydney - Fisaha Tesfay
• Improving quality and efficiency of cancer multidisciplinary team meetings across Victoria - Sian Wright
• Beyond Survival: Unmet Supportive Care Needs in Children and Adolescents Diagnosed with Cancer and a New Framework for Integrated Care   - Natalie Bradford
• Navigating cancer care: Access to Cancer Care Nurse Specialists and Multidisciplinary Care in Australia - Hannah TTH Truong
• From Emergency to Oncology: Improving Care Pathways Following a Cancer Diagnosis in the Emergency Department - Hannah TTH Truong
• An optimal care pathway for people living in rural and remote areas with cancer: Reducing inequities through outlining best practice cancer care - Anna Ugalde
• Clinical surrogate indicators of recurrent or metastatic disease for outcome assessment of real-world head and neck cancer data - Ivy Cerelia Valerie
• Development and experiences of sexual health counselling clinics at The Royal Women’s Hospital and Princess Margaret Cancer Centre.  - Wendy Vanselow
• Use of virtual outpatient oncology services by residential remoteness among adults with cancer in Australia: a population-based retrospective cohort study - Ramya Walsan
• Development of a Statewide Model of Care for Equitable Access to Cancer Genetic Services in New South Wales - Meera Warby
• Optimising colorectal cancer surveillance using clinical and lifestyle-based risk prediction models in people at increased risk of colorectal cancer - Molla Wassie
• Strengthening cultural safety through place-based learning: Reflections from an Australian Comprehensive Cancer Network delegation to the Northern Territory - Claire Howlett
• Walking Together: First Nations Clinical and Cultural Leadership Supporting the McGrath Nursing Workforce - Amy M Windisch
• Integrating dose modifications for effective management of HR+, HER2− early breast cancer with abemaciclib - Aarohan Pruthi
• Understanding access to cancer diagnosis and treatment in rural and remote Australia: perspectives of people with lived experience - Charlene Wright
• From Partnership to Practice: Adapting a Fear of Cancer Recurrence Clinical Pathway for Chinese-Speaking People Affected by Cancer - Verena S Wu
• Opportunities of Precision Oncology: Ensuring Equitable Access Nationally to Germline Validation - Milita Zaheed
• Retrospective audit of oncology and haematology patients requiring hospital admission to Western Health with COVID/Influenza/Respiratory Syncytial Virus (RSV) infection over a three-year period - Oliver Zhang
• Beyond commitment: Advancing cancer equity across G7 Cancer countries - Merilyn Penn
• The Australian Rare Cancer Portal: Service outcomes following national recommencement 2026 - Maryanne Akkerman
•  How CCNSW Practical Support services are alleviating financial toxicity   - Bianca Beetham
• VICS Care of the older person with cancer toolkit – a resource for implementation of the OCP for older people with cancer - Tracey Bucki
• Consumer co-design of Australia's first national metastatic breast cancer Information and Support Hub (mbchub): development and early implementation - Jill Carland
• Expanding the pharmacist’s role in patient-centred cancer care for a complex regional community - Courtney Castle
• From data to decisions: Using routinely collected cancer care data to support service planning and quality improvement   - Saeid Reza Kalbasi
• Building a digital legacy conversation aid into advance care planning services for people with advanced cancer - Masahiro Kuno
• Cancer treatment symptom navigator: a multilingual digital tool to support patient navigation and early symptom escalation - Stella Lee
• Holistic supportive care: Integrated financial, legal and emotional service delivery model  - Bianca Beetham
• Redevelopment of referral pathways for psycho-oncology clinic in a rural hospital - Hong Chuan Lin
• From global perspectives to local practice: a literature review to develop a framework for an early-onset cancer program in Australia  - Mei Sim Lung
• Novel models to support Nurse Practitioner prescribing competence: experience from Sunshine Coast Health. - Cassandra J Mazza
• Regional Exercise Oncology Program: Feasibility of Implementing a Standardised Prescriptive Exercise Program for Oncology Patients in the Latrobe Valley - Jordan McMillan
• Providing multilingual clinical trial information to support communication: A statewide initiative in NSW - Melissa Minett
• Your patients are our patients: embedding fertility preservation conversations into routine cancer care  - Aisling Murphy
• Reducing emergency presentation and Length of Stay (LoS) through an ambulatory paracentesis pathway for malignant ascites via the Rapid Access Clinic Expansion (RACE) - Martina O'Neill
• Embedding exercise and physical function support into routine chemotherapy care: The PACER service model   - Lisa E Parry
• From Pilot to Practice: implementing Patient Reported Measures across Sydney Local Health District - Eleanor Romney
• Developing a regional allied health oncology model of care across the cancer continuum of care in south west Victoria. - Madison Rush
• Limitless potential: developing an outpatient haematology and palliative care pharmacist role. - Jim Siderov
• Establishing a Lived Experience Advisory Forum at Cancer Council NSW  - Brenna Smith
• Using Reporting for Better Cancer Outcomes (RBCO) reporting to increase executive visibility of cancer clinical trial performance and access - Yang Song
• Early-onset cancer in Western Melbourne: an analysis of oncology outpatients - Yufei Su
• Postmortem Artificial Intelligence in Oncology: A Narrative Review and Preliminary Framework for Responsible Clinical Integration - Keito Suzuki
• Personalising care by design: how sustained consumer partnership shaped an early referral palliative care model for people with advanced cancer - Stacey Rich
• Feasibility of a nurse-led monitoring model for patients receiving vorasidenib for IDH-mutant grade 2 glioma - Angela Mellerick